BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 4358375)

  • 21. Prognostic value of host immunocompetence in urologic cancer patients.
    Catalona WJ; Smolev JK; Harty JI
    J Urol; 1975 Dec; 114(6):922-6. PubMed ID: 1195475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances in immunobiology of genitourinary cancer.
    Javadpour N; Scardino PT
    Urology; 1977 Apr; 9(4):377-84. PubMed ID: 67693
    [No Abstract]   [Full Text] [Related]  

  • 23. The cancer associated antigen test as an index to failure of complete removal of urological cancers.
    Wechsler M; Gerfo PL; Feminella J; Lattimer JK
    J Urol; 1973 Apr; 109(4):699-701. PubMed ID: 4735168
    [No Abstract]   [Full Text] [Related]  

  • 24. Tumour-associated antibodies against renal cell carcinomas detected by immunofluorescence.
    Ackermann R
    Eur Urol; 1975; 1(3):154-6. PubMed ID: 786650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-associated antigens in gynecologic cancer.
    DiSaia PJ
    Clin Obstet Gynecol; 1975 Dec; 18(4):87-108. PubMed ID: 765038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Plasma and urinary CEA-assay in patients with urological tumours (author's transl)].
    Hering H; Hering FJ; Weidner W
    Urologe A; 1976 Nov; 15(6):300-3. PubMed ID: 1006894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating immune complexes in human neuroblastoma: direct assay and role in blocking specific cellular immunity.
    Jose DG; Seshadri R
    Int J Cancer; 1974 Jun; 13(6):824-38. PubMed ID: 4136591
    [No Abstract]   [Full Text] [Related]  

  • 28. [The expression of lymphocytic function-associated antigen determined by IKO-11 monoclonal antibodies in patients with nephroblastoma and neuroblastoma].
    Torubarova NA; Baryshnikov AIu; Zikiriakhodzhaev DZ; Sukhanova EL; Kadagidze ZG
    Eksp Onkol; 1988; 10(2):39-42. PubMed ID: 2839330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of tumor-specific antigen and antibody in kidneys of neuroblastoma-bearing mice.
    Terman DS; Durante D; Racic M; McIntosh RM
    Proc Soc Exp Biol Med; 1977 May; 155(1):137-41. PubMed ID: 859874
    [No Abstract]   [Full Text] [Related]  

  • 30. Carcinoembryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome.
    Costanza ME; Pinn V; Schwartz RS; Nathanson L
    N Engl J Med; 1973 Sep; 289(10):520-2. PubMed ID: 4579334
    [No Abstract]   [Full Text] [Related]  

  • 31. Renal tubular antigens in kidney tumors.
    Wallace AC; Nairn RC
    Cancer; 1972 Apr; 29(4):977-81. PubMed ID: 4335980
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunological evaluation in patients with urological cancers.
    Martinez-PiƱeiro JA; Muntanola P; Hidalgo L
    Eur Urol; 1977; 3(3):159-62. PubMed ID: 560302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunobiology of cancer].
    Oettgen HF
    Arch Klin Exp Ohren Nasen Kehlkopfheilkd; 1973; 205(1):21-36. PubMed ID: 4349192
    [No Abstract]   [Full Text] [Related]  

  • 34. Serum induced lymphoid cell mediated cytotoxicity to human transitional cell carcinomas of the genitourinary tract.
    Hakala TR; Lange PH
    Science; 1974 May; 184(4138):795-7. PubMed ID: 4856602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro testing in tumor immunotherapy.
    Berkelhammer J
    Semin Oncol; 1974 Dec; 1(4):397-408. PubMed ID: 4143489
    [No Abstract]   [Full Text] [Related]  

  • 36. In vitro methods for assessment of antibody-mediated tumor immunity.
    Levy NL; Amos DB; Solovieff GV; dos Reis AP
    Natl Cancer Inst Monogr; 1972 Dec; 35():5-11. PubMed ID: 4349154
    [No Abstract]   [Full Text] [Related]  

  • 37. The effects of treatment on delayed cutaneous hypersensitivity responses (DNCB, croton oil, and recall antigen) in patients with genitourinary cancer.
    Elhilali MM; Brosman SA; Vescera C; Paul JG; Fahey JL
    Cancer; 1978 May; 41(5):1765-70. PubMed ID: 647626
    [No Abstract]   [Full Text] [Related]  

  • 38. Cell-mediated cytotoxicity against human bladder cancer.
    Bloom ET; Ossorio RC; Brosman SA
    Int J Cancer; 1974 Sep; 14(3):326-34. PubMed ID: 4477556
    [No Abstract]   [Full Text] [Related]  

  • 39. In vitro cytotoxicity studies in bladder and renal cell cancer.
    Elhilali MM; Nayak SK
    Urology; 1976 May; 7(5):488-91. PubMed ID: 1274005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunologic evaluation of human renal cell carcinoma. In vitro studies.
    Elhilali MM; Nayak SK
    Invest Urol; 1975 Jul; 13(1):60-6. PubMed ID: 49333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.